RxDoctor Payments Data

Adam Brunson, MD

Family Medicine · St Petersburg, FLNPI 1023011913

Payments from drug & device makers

$1,552in general payments, 2019–2025

Across 85 payments — averaging $18.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$516
  • AbbVie$211
  • AstraZeneca$202
  • GSK$140
  • Lilly USA, LLC$100
  • Eisai Inc.$87
  • plus $295 from 9 others

What the payments were for

  • Food & beverage$1,552100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,552 in reported general payments places this provider in the 70th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$150,104
Medicare patients
216
Services billed
3,215

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RybelsusSemaglutide24$32,802
JardianceEmpagliflozin24$28,399
EliquisApixaban30$26,296
FarxigaDapagliflozin Propanediol23$24,834
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$14,254
EntrestoSacubitril/Valsartan12$13,632
Praluent PenAlirocumab12$5,841
Testosterone23$5,296
Atorvastatin Calcium258$2,282
Testosterone Cypionate36$2,007
SynthroidLevothyroxine Sodium22$1,525
Rosuvastatin Calcium129$1,511
Potassium Chloride29$1,341
Butalb-Acetaminoph-Caff-CodeinButalbit/Acetamin/Caff/Codeine12$1,288
Losartan Potassium115$1,254

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus$516$32,80224 claims
PfizerEliquis$34$26,29630 claims
AstraZenecaFarxiga$202$24,83423 claims
GSKTrelegy Ellipta$140$14,25415 claims
AbbVieSynthroid$211$1,52522 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,282 family medicine providers in Florida.

Other family medicine in St Petersburg

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →